bpc 157 for bicep tendonitis Injectable Healing Peptide BPC-157 Subcutaneous Site Injection Instructional Video w/ John Tsikouris What Science ACTUALLY Says About

Copyright 2026 Elite IV Infusion

To learn more about the various Peptide therapies available at Thrive call or text our office at (303) 790-8446 for a free phone consultation today

The benefit is that these treatments can often reduce the need for expensive surgeries or long-term drugs

You're likely a reasonable candidate if: You've been symptomatic for more than 12 weeks with confirmed or highly probable prior SARS-CoV-2 infection Standard care has not produced adequate improvement You have a clear symptom cluster that maps to one or more of the mechanisms above You're willing to undergo baseline labs and ongoing clinical monitoring You understand that peptide therapy is an emerging not established intervention for this indication You may need to address other issues first if: Active autoimmune conditions are not yet stabilised You have unmanaged cardiovascular disease You're currently immunosuppressed for another reason You haven't yet tried evidence-based long COVID rehabilitation approaches The most important step is working with a clinician who understands both long COVID pathophysiology and peptide pharmacology not one who simply offers a generic protocol